On Cancer

Filter by Tag

Pictured: Jedd Wolchok & Richard Carvajal

In the Clinic

Memorial Sloan-Kettering Researchers Report on Major Advances in the Treatment of Metastatic Eye and Skin Melanoma

By Media Staff | Monday, June 3, 2013

Two Memorial Sloan-Kettering studies that hold promise for the treatment of advanced uveal (eye) melanoma and advanced skin melanoma are making headlines at the 49th Annual Meeting of the American Society of Clinical Oncology.

Tags: Cancer Care; Research; Clinical Research; Clinical Trials; Immunotherapy; Treatment; Melanoma; Skin Cancer

In the Clinic

Combining Two FDA-Approved Drugs May Be Harmful for Patients with Metastatic Melanoma

By Media Staff | Thursday, April 4, 2013

Early research led by investigators at Memorial Sloan-Kettering cautions against combining ipilimumab and vemurafenib for the treatment of metastatic melanoma.

Tags: Cancer Care; Research; Clinical Research; Clinical Trials; Immunotherapy; Treatment; Melanoma

In the Lab

Study Reveals Immune Response as Potential Biomarker to Predict Recurrence of Lung Cancer

By Julie Grisham, MS, Science Writer/Editor | Thursday, January 3, 2013

A team from Memorial Sloan-Kettering has found that the makeup of immune cells in a lung tumor and in tissue surrounding a tumor can predict whether the cancer will recur after surgery.

Tags: Lab Research; Research; Immunotherapy; Immunology; Lung Cancer

In the Lab

New Technique Could Make Cell-Based Immune Therapies for Cancer Safer and More Effective

By Julie Grisham, MS, Science Writer/Editor | Tuesday, December 18, 2012

Memorial Sloan-Kettering researchers have reported a new method that could allow the development of more-specific, cell-based therapies for cancer.

Tags: Lab Research; Research; Immunotherapy; Cell Therapy; Immunology

Pictured: Michel Sadelain & Jedd Wolchok

Announcement

Memorial Sloan-Kettering Researchers Appointed to Stand Up To Cancer Immunology “Dream Team”

By Media Staff | Wednesday, December 12, 2012

Physician-scientists Michel Sadelain and Jedd Wolchok have been appointed to a new research team dedicated to investigating ways to harness the immune system to fight cancer.

Tags: Research; Immunotherapy; Immunology

Pictured: Jedd Wolchok and James Allison

In the News

The New Yorker Features Immune Therapy Work of Memorial Sloan-Kettering Researchers

By Media Staff | Friday, April 20, 2012

In an article describing the history and promise of immunotherapy for cancer treatment, the magazine highlights the groundbreaking work of James Allison, Chair of the Sloan-Kettering Institute’s Immunology Program, and medical oncologist and immunologist Jedd Wolchok.

Tags: Research; Immunotherapy; Immunology

In the Clinic

Rare Medical Phenomenon: Melanoma Patient’s Tumors Disappear throughout the Body after Radiation of One Tumor

By Media Staff | Thursday, March 8, 2012

Findings from a multidisciplinary research team led by Memorial Sloan-Kettering medical oncologist and immunologist Jedd Wolchok could help shed light on the immune system’s role in fighting cancer.

Tags: Research; Clinical Research; Immunotherapy; Radiation Therapy; Immunology; Melanoma

Pictured: Isabelle Rivière, Michel Sadelain & Renier Brentjens

Feature

Cell-Based Therapies Show Promise

By Julie Grisham, MS, Science Writer/Editor | Wednesday, December 28, 2011

Years of innovative research, technology development, and facility expansion at Memorial Sloan-Kettering have led to several new experimental treatments for people with cancer.

Tags: Research; Cell Engineering; Immunotherapy; Cell Therapy; Drug Discovery; Experimental Therapeutics

In the Lab

Researchers Show Therapy Could Improve Stem Cell Transplants

By Julie Grisham, MS, Science Writer/Editor | Monday, December 12, 2011

A Memorial Sloan-Kettering study suggests that a new, experimental treatment could make bone marrow and stem cell transplantation safer and more effective.

Tags: Blood & Marrow Stem Cell Transplantation; Research; Immunotherapy; Drug Discovery; Immunology